These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11868533)

  • 1. [Keratinocyte immunophenotypes in patients with psoriatic arthritis and their changes after treatment with deresinated naphthalan].
    Badalov NG; Tupitsyn NN; Grigor'eva VD
    Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (6):32-4. PubMed ID: 11868533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotype characteristics of skin dendritic cells in patients with psoriatic arthritis during the treatment with deresinated naphthalan].
    Badalov NG; Tupitsyn NN; Grigor'eva VD
    Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (4):29-32. PubMed ID: 11561301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deresinated naphthalan in the treatment of psoriatic arthritis].
    Grigor'eva VD; Badalov NG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (4):13-5. PubMed ID: 7846875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthalanotherapy reduces angiogenetic factor in psoriatic lesion.
    Vrzogić P; Jakić-Razumović J; Lipozencić J
    Acta Dermatovenerol Croat; 2004; 12(1):7-11. PubMed ID: 15072742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological phenotype of skin lymphoid cells in patients with psoriatic arthritis during rehabilitation].
    Badalov NG; Tupitsyn NN; Grigor'eva VD
    Vopr Kurortol Fizioter Lech Fiz Kult; 2003; (5):8-12. PubMed ID: 14650125
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
    Cordiali-Fei P; Trento E; D'Agosto G; Bordignon V; Mussi A; Ardigó M; Mastroianni A; Vento A; Solivetti F; Berardesca E; Ensoli F
    Ann N Y Acad Sci; 2007 Sep; 1110():578-89. PubMed ID: 17911474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical markers for arthritis in psoriasis.
    Veale DJ; Barnes L; Rogers S; FitzGerald O
    Ann Rheum Dis; 1994 Jul; 53(7):450-4. PubMed ID: 7944617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis.
    Queiro-Silva R; Torre-Alonso JC; Tinturé-Eguren T; López-Lagunas I
    Scand J Rheumatol; 2004; 33(5):318-22. PubMed ID: 15513680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of CD208 (DC-LAMP) in epidermal keratinocytes of psoriatic lesions.
    Higaki M; Higaki Y; Kawashima M
    J Dermatol; 2009 Mar; 36(3):144-9. PubMed ID: 19335688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics in patients with psoriatic arthritis].
    Imre K; Koó E; Seszták M; Bosák V; Bitterova O
    Orv Hetil; 2006 Dec; 147(50):2415-9. PubMed ID: 17274187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New signposts on the road to understanding psoriatic arthritis.
    Vasey FB; Seleznick MJ; Fenske NA; Espinoza LR
    J Rheumatol; 1989 Nov; 16(11):1405-7. PubMed ID: 2574747
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of the ultraphonophoesis of deresinated naphthalan in patients with a history of exudative pleurisy].
    Insanov AB; Musaev AV; Gazvinova EA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1995; (6):18-20. PubMed ID: 8713301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden.
    Alenius GM; Jidell E; Nordmark L; Rantapää Dahlqvist S
    Clin Rheumatol; 2002 Sep; 21(5):357-62. PubMed ID: 12223981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulation in psoriasis and psoriatic arthritis--recent developments.
    Hueber AJ; McInnes IB
    Immunol Lett; 2007 Dec; 114(2):59-65. PubMed ID: 17928070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
    Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: a potential role in the pathogenesis of psoriatic arthropathy.
    Lan CC; Tsai WC; Wu CS; Yu CL; Yu HS
    Br J Dermatol; 2004 Jul; 151(1):24-31. PubMed ID: 15270869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
    Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
    Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in laboratory research?
    Pincelli C; Lotti R
    J Rheumatol Suppl; 2009 Aug; 83():17-8. PubMed ID: 19661530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.